These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 476386)

  • 1. The value of a tracer dose in predicting the kinetics of therapeutic doses of 131I in thyrotoxicosis.
    O'Connor MK; Cullen MJ; Malone JF
    Br J Radiol; 1979 Sep; 52(621):719-26. PubMed ID: 476386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A thermoluminescent method for estimation of effective thyroidal half-life of therapeutic 131I in toxic goitre.
    Malone JF; Cullen MJ
    Br J Radiol; 1975 Sep; 48(573):762-4. PubMed ID: 1182436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of tracer studies for 131I treatment in hyperthyroid cats.
    Broome MR; Turrel JM; Hays MT
    Am J Vet Res; 1988 Feb; 49(2):193-7. PubMed ID: 3348530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The importance of the radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases].
    Nüchel C; Boddenberg B; Schicha H
    Nuklearmedizin; 1993 Apr; 32(2):91-8. PubMed ID: 8479936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of antithyroid medication on the effective half-life and uptake of 131-iodine following radioiodine therapy].
    Moka D; Voth E; Schicha H
    Nuklearmedizin; 1997 Apr; 36(3):87-92. PubMed ID: 9162907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single uptake measurement for absorbed dose planning for radioiodine treatment of hyperthyroidism.
    Jönsson H; Mattsson S
    Cancer Biother Radiopharm; 2003 Jun; 18(3):473-9. PubMed ID: 12954135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorbed doses in the marrow during 131I therapy.
    McEwan AC
    Br J Radiol; 1977 May; 50(593):329-31. PubMed ID: 861452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioprotective action of carbimazole in radioiodine therapy for thyrotoxicosis--influence of the drug on iodine kinetics.
    Connell JM; Hilditch TE; Robertson J; Coghill G; Alexander WD
    Eur J Nucl Med; 1987; 13(7):358-61. PubMed ID: 3428285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected dose to the daughter of a patient treated with iodine-131 for hyperthyroidism.
    Molyvda-Athanasopoulou E; Karaveli M; Chatzigiannaki A; Gotzamani-Psarrakou A
    Hell J Nucl Med; 2007; 10(3):175-6. PubMed ID: 18084660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
    Coover LR; Silberstein EB; Kuhn PJ; Graves MW
    J Nucl Med; 2000 Nov; 41(11):1868-75. PubMed ID: 11079497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the risk of developing hyperparathyroidism after 131I treatment for thyrotoxicosis.
    Fjälling M; Dackenberg A; Hedman I; Tisell LE
    Acta Chir Scand; 1983; 149(7):681-6. PubMed ID: 6650083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is a dosage calculation for radio-iodine therapy possible?].
    Creutzig H; Hundeshagen H
    Nuklearmedizin; 1976 Oct; 15(5):233-6. PubMed ID: 1005129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: is more than seven-thousand rad target dose necessary?
    Bajnok L; Mezosi E; Nagy E; Szabo J; Sztojka I; Varga J; Galuska L; Leovey A
    Thyroid; 1999 Sep; 9(9):865-9. PubMed ID: 10524564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and radiobiological bases of the use of 125I in the management of thyrotoxicosis.
    Reddy AR
    Radiat Environ Biophys; 1976 Oct; 13(3):205-14. PubMed ID: 790444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of carbimazole following radioiodine therapy on radiation dose to the thyroid.
    Gimlette TM; Kocak R; Herbert RG; Squire CR
    Nuklearmedizin; 1981 Apr; 20(2):72-5. PubMed ID: 6165965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between severity of thyrotoxicosis and response to 131I therapy.
    Olsen KJ; Nielsen HE; Hansen HH
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(6):517-23. PubMed ID: 735855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotoxicosis in Sierra Leone: diagnosis and treatment with radioactive iodine (131I).
    Knox-Macaulay HH
    Trop Geogr Med; 1982 Jun; 34(2):169-75. PubMed ID: 7123649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.